Acute Bacterial Meningitis

ABSTRACT

In the past 10 years the epidemiology of bacterial meningitis has changed, with a decreased incidence of meningitis caused by Haemophilus influenzae and an increasing incidence of meningitis caused by penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae. Meningococcal meningitis has become an increasing threat to college students. Successful outcome from meningitis requires not only eradication of the bacterial pathogen but also management of the neurological complications of raised intracranial pressure, stroke, and seizure activity. In this article, the pathophysiology, etiology, clinical presentation, differential diagnosis, and management of acute bacterial meningitis are reviewed. The present recommendations for the use of dexamethasone in the treatment of this infection, the use of chemoprophylaxis, and the indications for vaccinations are included.

KEYWORD

Bacterial meningitis - dexamethasone - vaccination

REFERENCES

• 1 Vieusseux G. Mémoire sur la maladie qui a régne a Geneve au printemps de 1805.  J Med Chi Pharm . 1806;  11 163-182
• 2 Danielson L, Mann E. The history of a singular and very mortal disease which lately made its appearance in Medfield. In: Adams B, ed. The Medical and Agricultural Register Boston: Manning and Loring 1806: 65-69
• 3 Verghese A, Gallemore G. Kernig's and Brudzinski's signs revisited.  Rev Infect Dis . 1987;  9 1187-1192
• 4 Quincke H. Uber hydrocephalus, Verhandlungen des Congressus fur innere Medizin. Vol 10. Wiesbaden: JF Bergman 1891: 321
• 5 Macfarlane G. Alexander Fleming: The Man and the Myth. Oxford: Oxford University Press 1985: 117-127
• 6 Scheld W M, Mandell G L. Sulfonamides and meningitis.  JAMA . 1984;  251 791-794
• 7 Schwentker F F, Gelman S, Long P H. The treatment of meningococcic meningitis with sulfanilamide.  JAMA . 1984;  251 788-790
• 8 Bell W E, Silber D L. Meningococcal meningitis: past and present concepts.  Mil Med . 1971;  136 601-611
• 9 Rosenberg D H, Arling P A. Penicillin in the treatment of meningitis.  JAMA . 1944;  125 1011-1017
• 10 Tauber M G, Sande M A. The impact of penicillin on the treatment of meningitis.  JAMA . 1984;  251 1877-1880
• 11 Simberkoff M S, Moldover N H, Rahal Jr J. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids: a regional host defense deficiency.  J Lab Clin Med . 1980;  95 362-367
• 12 Tauber M G, Moser B. Cytokines and chemokines in meningeal inflammation: biology and clinical implications.  Clin Infect Dis . 1999;  28 1-12
• 13 Pfister H W, Borasio G D, Dirnagl U, Bauer M, Einhaupl K M. Cerebrovascular complications of bacterial meningitis in adults.  Neurology . 1992;  42 1497-1504.
• 14 Feigin R D, McCracken G H, Klein J O. Diagnosis and management of meningitis.  Pediatr Infect Dis J . 1992;  11 785-814
• 15 Hoban D J, Witwicki E, Hammond G W. Bacterial antigen detection in cerebrospinal fluid of patients with meningitis .  Diagn Microbiol Infect Dis . 1985;  3 373-379
• 16 Maxson S, Lewno M J, Schutze G E. Clinical usefulness of cerebrospinal fluid bacterial antigen studies.  J Pediatr . 1994;  125 235-238
• 17 Dwelle T L, Dunkle L M, Blair L. Correlation of cerebrospinal fluid endotoxin-like activity with clinical and laboratory variables in gram-negative bacterial meningitis in children .  J Clin Microbiol . 1987;  25 856-858
• 18 Fishman R A. CSF findings in diseases of the nervous system. In: Fishman RA, ed. Cerebrospinal Fluid in Diseases of the Nervous System Philadelphia: WB Saunders 1992: 253-343
• 19 Durack D T, Spanos A. End-of-treatment spinal tap in bacterial meningitis: is it worthwhile? .  JAMA . 1982;  248 75-78
• 20 National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing Villanova, PA: National Committee for Laboratory Standards; 1994
• 21 Sanders C C. Cefepime: the next generation?.  Clin Infect Dis . 1993;  17 369-379
• 22 Saez-Llorens X, Castano E, Garcia R. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children.  Antimicrob Agents Chemother . 1995;  39 937-940
• 23 Patel J B, Giles R E. Meropenem: Evidence of lack of proconvulsive tendency in mice.  J Antimicrob Chemother . 1989;  307-309 (307-309)
• 24 Lepper M H, Spies H W. Treatment of pneumococcic meningitis.  AMA Arch Intern Med . 1959;  104 253-259
• 25 Tauber M G, Khayam-Bashi H, Sande M. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis.  J Infect Dis . 1985;  151 528-534
• 26 Lebel M H, Freij B, Syrogiannopoulos G A. Dexamethasone therapy for bacterial meningitis.  N Engl J Med . 1988;  319 964-971
• 27 Lebel M H, Hoyt M J, Waagner D C, Rollins N K, Finitzo T, McCracken G H. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis .  Am J Dis Child . 1989;  143 301-306
• 28 Girgis N I, Farid Z, Mikhail I A, Farrag I, Sultan Y, Kilpatrick M E. Dexamethasone treatment for bacterial meningitis in children and adults .  Pediatr Infect Dis J . 1989;  8 848-851
• 29 Odio C M, Faingezicht I, Paris M. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.  N Engl J Med . 1991;  324 1525-1531
• 30 Schaad U B, Lips U, Gnehm H E, Blumberg A, Heinzer I, Wedgewood J. Dexamethasone therapy for bacterial meningitis in children.  Lancet . 1993;  342 457-461
• 31 King S M, Law B, Langley J M. Dexamethasone therapy for bacterial meningitis: better never than late? .  Can J Infect Dis . 1994;  5 210-215
• 32 Wald E R, Kaplan S L, Mason E O. Dexamethasone therapy for children with bacterial meningitis.  Pediatrics . 1995;  95 21-28
• 33 Kilpi T, Peltola H, Jauhiainen T, Kallio M J. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis.  Pediatr Infect Dis J . 1995;  14 270-278
• 34 Ciana G, Antonio C, Pivetta S, Tamburlini G, Cuttini M. Effectiveness of adjunctive treatment with steroids in reducing short-term mortality in a high-risk population of children with bacterial meningitis .  J Trop Pediatr . 1995;  41 164-168
• 35 Kanra G Y, Ozen H, Secmeer G, Ceyhan M, Ecevit Z, Belgin E. Beneficial effects of dexamethasone in children with pneumococcal meningitis .  Pediatr Infect Dis J . 1995;  14 490-494
• 36 Qazi S, Khan M A, Mughal N. Dexamethasone and bacterial meningitis in Pakistan.  Arch Dis Child . 1996;  75 482-488
• 37 McIntyre P B, Berkey C S, King S M. Dexamethasone as adjunctive therapy in bacterial meningitis.  JAMA . 1997;  278 925-931
• 38 Paris M M, Hickey S M, Uscher M I, Shelton S, Olsen K D, McCracken G H. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.  Antimicrob Agents Chemother . 1994;  38 1320-1324
• 39 Cabellos C, Martinez-Lacasa J, Martos A. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.  Antimicrob Agents Chemother . 1995;  39 2158-2160
• 40 Klugman K P, Friedland I R, Bradley J S. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.  Antimicrob Agents Chemother . 1995;  39 1988-1992
• 41 Viladrich P F, Gudiol F, Linares J. Evaluation of vancomycin for therapy of adult pneumococcal meningitis .  Antimicrob Agents Chemother . 1991;  35 2467-2472
• 42 Harrison L H, Dwyer D M, Maples C T, Billmann L. Risk of meningococcal infection in college students.  JAMA . 1999;  281 1906-1909
• 43 Peltola H. Prophylaxis of bacterial meningitis.  Infect Dis Clin North Am . 1999;  13 685-706